Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Sharpe

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
American Journal of Ophthalmology|June 15, 1985
Argon laser trabeculoplasty as a means of decreasing intraocular pressure from "normal" levels in glaucomatous eyesE D Sharpe, R J Simmons
Ophthalmic Surgery|May 1, 1986
Argon laser therapy of occult recurrent hyphema from anterior segment wound neovascularizationE D Sharpe, R J Simmons
Journal of Cataract and Refractive Surgery|January 1, 1986
A prospective comparison of Amvisc and Healon in cataract surgeryE D Sharpe, R J Simmons
American Journal of Ophthalmology|March 10, 2001
Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%W C Stewart, E D Sharpe, J A Stewart, et al.
Eye (London, England)|March 24, 2004
Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapyW C Stewart, J A Stewart, D G Day, et al.
Eye (London, England)|June 4, 2005
The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patientsD G Day, E D Sharpe, M J Atkinson, et al.
The British Journal of Ophthalmology|June 19, 2004
Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertensionE D Sharpe, D G Day, C J Beischel, et al.
European Journal of Ophthalmology|June 10, 2005
Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%/dorzolamide 2% fixed combinationD G Day, E D Sharpe, C J Beischel, et al.
American Journal of Ophthalmology|December 28, 1999
Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprostW C Stewart, D G Day, E D Sharpe, et al.
American Journal of Ophthalmology|August 6, 2000
Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressureW C Stewart, E D Sharpe, T S Harbin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
American Journal of Ophthalmology|June 15, 1985
Argon laser trabeculoplasty as a means of decreasing intraocular pressure from "normal" levels in glaucomatous eyesE D Sharpe, R J Simmons
Ophthalmic Surgery|May 1, 1986
Argon laser therapy of occult recurrent hyphema from anterior segment wound neovascularizationE D Sharpe, R J Simmons
Journal of Cataract and Refractive Surgery|January 1, 1986
A prospective comparison of Amvisc and Healon in cataract surgeryE D Sharpe, R J Simmons
American Journal of Ophthalmology|March 10, 2001
Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%W C Stewart, E D Sharpe, J A Stewart, et al.
Eye (London, England)|March 24, 2004
Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapyW C Stewart, J A Stewart, D G Day, et al.
Eye (London, England)|June 4, 2005
The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patientsD G Day, E D Sharpe, M J Atkinson, et al.
The British Journal of Ophthalmology|June 19, 2004
Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertensionE D Sharpe, D G Day, C J Beischel, et al.
European Journal of Ophthalmology|June 10, 2005
Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%/dorzolamide 2% fixed combinationD G Day, E D Sharpe, C J Beischel, et al.
American Journal of Ophthalmology|December 28, 1999
Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprostW C Stewart, D G Day, E D Sharpe, et al.
American Journal of Ophthalmology|August 6, 2000
Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressureW C Stewart, E D Sharpe, T S Harbin, et al.
Pageof 2